Registered number: 12352146

Merlin Pharma Consulting Ltd
Unaudited Financial Statements
for the year ended 31 December 2025

Statement of Financial Position

as at 31 December 2025

  2025
2024
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  4,637  
 
  7,400  
Current assets  
12,856    
 
21,946    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
-    
 
( 3,869 )  
Net current assets (liabilities)  
  12,856  
 
  18,077  
Total assets less current liabilities  
  17,493  
 
  25,477  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  -  
 
  -  
Net assets  
  17,493  
 
  25,477  
   
Capital and reserves  
  17,493  
 
  25,477  

xbrli:pure 12352146 2025-01-01 2025-12-31 12352146 2024-01-01 2024-12-31 12352146 2025-12-31 12352146 2024-12-31 12352146 2025-01-01 12352146 uk-frs102:WithinOneYear 2025-12-31 12352146 uk-frs102:AfterOneYear 2025-12-31 12352146 uk-frs102:WithinOneYear 2024-12-31 12352146 uk-frs102:AfterOneYear 2024-12-31 12352146 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 12352146 uk-bus:FilletedAccounts 2025-01-01 2025-12-31 12352146 uk-bus:Director1 1 2025-01-01 2025-12-31 12352146 uk-bus:Director1 2025-01-01 2025-12-31 12352146 uk-bus:Director1 1 2025-01-01 12352146 uk-bus:Director1 1 2025-12-31 12352146 uk-bus:Micro-entities 2025-01-01 2025-12-31 12352146 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 iso4217:GBP 12352146 countries:EnglandWales 2025-01-01 2025-12-31 12352146 uk-bus:RegisteredOffice 2025-01-01 2025-12-31

Footnotes to the Statement of Financial Position

Jason Cooke

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

The Director Jason Cooke, has no amount owing to the company at the opening or closing date of the Statement of Financial Position.

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 31/12/2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 12352146

c) The company is a private company and is limited by shares

d) The company's registered office address is Ashridge Barn London Road Bolney, Haywards Heath, RH17 5QB, England

e) Company ceased to trade on 31/12/2025



Approved by the board of directors and signed on behalf of the board,

Merlin Pharma Consulting Ltd
Director Jason Cooke
Date of approval: 15/07/2026
The company was trading for the entire period 2025-01-01 2025-12-31 2025-12-31 Pharmaceutical Consulting 2026-07-15 2026-07-15